 |
26 Diseases |  |
6 Trials |
|
6 Trials |  |
4342 News |  |
| «12...2021222324252627282930...5051» |
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
So what are you going to do? Still prescribe Vascepa or nah? LOL I want to believe (Twitter) - Nov 15, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Actually the best experiment would be ex vivo. Dose patients in the Reduce It population on statin with Lovaza or Vascepa to steady state and collect blood samples. Normalize LDL levels and induce oxidation. (Twitter) - Nov 15, 2020
- ||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
Clinical, Interview: UPDATE: As the day unfolded, REDUCE-IT investigator @DLBHATTMD agreed in an interview that results from #STRENGTH bolster the case for EPA-only therapy. He called the whole episode "manufactured controversy." #Vascepa https://t.co/ipmrxITokw via @MHExecutive (Twitter) - Nov 15, 2020
- || Omtryg (omega-3 acid ethyl esters) / Aker Biomarine, Trygg Pharma, Vascepa (icosapent ethyl) / Amarin, HLS Therap, Epanova (eicosapentaenoic acid/docosahexaenoic acid) / AstraZeneca
Start with Lovaza or Omtryg formulations versus icosapent ethyl. If there’s a clear difference than it’s probably worth pursuing Epanova. The exact mix of Epanova ingredients is publicly available in several patents - but straight out of the capsule seems most convincing. (Twitter) - Nov 15, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
UPDATES w. comments, background from @DLBHATTMD. "The whole thing is manufactured controversy in my opinion." Fish Oil Debate Continues as Study Finds No Risk Reduction From Omega-3 Combo #Vascepa https://t.co/JjF5P63Zns via @AJMC_Journal (Twitter) - Nov 15, 2020
- ||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
Clinical: What I just mentioned to @purviparwani is that maybe doctors should be cautious when prescribing Vascepa in patients ins sinus rhythm with enlarged left atria... (Twitter) - Nov 15, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap, Epanova (eicosapentaenoic acid/docosahexaenoic acid) / AstraZeneca
Mason should assess the Epanova formulation versus Vascepa with this same methodology - that would be convincing (Twitter) - Nov 15, 2020
- |||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
Clinical: Thank you for your continued support of patients with cardiovascular disease. Vascepa has been life changing drug in my efforts to manage my disease. (Twitter) - Nov 15, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Well written. Perhaps you want to invite @DLBHATTMD into this discussion. As for me, I remain a strong advocate for Vascepa. (Twitter) - Nov 15, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Updates w. excerpt on mineral oil issue from @ESC_Journals co-authored by @DLBHATTMD New Omega-3 Studies Raise Questions About REDUCE-IT Results for Vascepa https://t.co/ipmrxITokw via @MHExecutive (Twitter) - Nov 15, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Glad @DLBHATTMD was the guiding light of Reduce It and the voice of the paradigm shift in CVD that is Vascepa (Twitter) - Nov 15, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Vascepa crew could use their industry affiliations to get a deal on it. #academy4sale (Twitter) - Nov 15, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Vascepa crew should all take mineral oil on the daily for the next 4 years. It's apparently benign. (Twitter) - Nov 15, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Everything you wanted to know about #icosapentethyl and more! (Twitter) - Nov 15, 2020
- |||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
Clinical: IMHO, to reduce dyslipidemic residual risk, esp. in pts with extensive CAD and prior revasc., the goal should be LDL <40mg/dL plus PCSK9i, if needed. Also, need to measure TG (esp. in T2DM) and use icosapent ethyl for optimal lipid control. Ideal TG target is probably <70mg/dL. (Twitter) - Nov 15, 2020
- ||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
Clinical: I think this placebo issue is a lot of manufactured controversy, but for anyone genuinely concerned, I would point them to the randomized JELIS trial (no placebo) in @TheLancet showing a lower dose of icosapent ethyl (1.8 g) resulted in a 19% RRR. https://t.co/3WPc96dtGl (Twitter) - Nov 15, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Check out the imaging EVAPORATE study showing Icosapent Ethyl's impact on plaque. See it with your own eyes. (Twitter) - Nov 15, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
I hear @DLBHATTMD … a person for whom I have much respect… and effect size in REDUCEIT was large… but STRENGTH trial cannot be ignored either. Is there something specific to solo use of icosapent ethyl? We do need to unpack the differences in the drugs and trials. (Twitter) - Nov 15, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Well said and thank you again @toddneale for articulating the contrast of Reduce IT proving the benefits Vascepa versus Strength proving that fish oil doesn’t help. (Twitter) - Nov 15, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Steven Nissen @ClevelandClinic says the negative STRENGTH trial throws the 25% CVD event reduction with icosapent ethyl into doubt, but @DLBHATTMD says absolutely not. (Twitter) - Nov 15, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Deepak Bhatt defends REDUCE-IT: “Icosapent ethyl in two different independent trials showed significant reductions in ischemic events. So I think at a certain point it’s just ridiculous to not believe something." #AHA20 @DLBHATTMD https://t.co/e7SJKXpMc0 (Twitter) - Nov 15, 2020
- ||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
Clinical: To understand the truth about EPA and icosapent ethyl, make sure to see our comprehensive supplement available freely online at @ESC_Journals. Two independent randomized trials - REDUCE-IT (placebo) and JELIS (no placebo) - prove it works. https://t.co/NnAwriIwWN #cardiotwitter (Twitter) - Nov 15, 2020
- ||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
Definitely not by using Hikma's Generic Vascepa which only contains 60-80% icosapent ethyl. (Twitter) - Nov 14, 2020
- | Vascepa (icosapent ethyl) / Amarin, HLS Therap
Journal: Triglycerides and residual risk. (Pubmed Central) - Nov 14, 2020
Moreover, genetic studies support a causal link between TRL/triglycerides and cardiovascular disease. Treatment with high-dose EPA may be of benefit in high-risk patients with hypertriglyceridemia to reduce CVRisk.
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Now posted online at #AHA20 are the results of investigator-reported versus adjudicated events from REDUCE-IT - bottom line, icosapent ethyl works any way you slice the data: https://t.co/T5R5GY4JJ7 #cardiotwitter @gabrielsteg @CMichaelGibson @duanepinto @BudoffMd @mmillermd1 (Twitter) - Nov 14, 2020
- | Vascepa (icosapent ethyl) / Amarin, HLS Therap
Take you Vascepa (Twitter) - Nov 12, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Is this vascepa? It made my legs swell up. I feel like it's the happy fun ball. (Twitter) - Nov 11, 2020
- |||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
Could findings from the REDUCE-IT trial on icosapent ethyl help us reduce #ASCVD events? https://t.co/GvpYBq3eLd #Cardiology #CardioTwitter @DLBHATTMD (Twitter) - Nov 11, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Vascepa is >=96% EPA-E (page 131, pharma/toxicology table) https://t.co/HZNGOiIJID 98% purity from 1 mfg (page 8) https://t.co/S25RJlbEPB Label shows 1g per 1g-capsule https://t.co/aZ8qfEnkkP (Twitter) - Nov 10, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Per 1g capsule 60-.80% IPE? Is that a joke? How can FDA allow such capsule as "generic alternative", if 1g Vascepa contains almost 100% IPE? (Twitter) - Nov 10, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Is there a similar label that shows % of icosapent ethyl for Vascepa? (Twitter) - Nov 10, 2020
- |||| icosapent ethyl / Generic mfg.
Trial completion date, Trial primary completion date, Surgery: EMT2: EPA for Metastasis Trial 2 (clinicaltrials.gov) - Nov 9, 2020
P3, N=448, Recruiting, Sponsor: Mark A Hull, PhD FRCP
Treatment with high-dose EPA may be of benefit in high-risk patients with hypertriglyceridemia to reduce CVRisk. Trial completion date: Jan 2023 --> Jul 2025 | Trial primary completion date: Jan 2022 --> Jul 2024
- Vascepa (icosapent ethyl) / Amarin, HLS Therap
[VIRTUAL] Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI () - Nov 7, 2020 - Abstract #TCT2020TCT_661;
Trial completion date: Jan 2023 --> Jul 2025 | Trial primary completion date: Jan 2022 --> Jul 2024 In statin-treated patients with elevated triglycerides and a history of PCI, the addition of icosapent ethyl significantly reduced ischemic events, with relative and absolute risk reductions that were substantial.
- ||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
$AMRN @DLBHATTMD what are your thoughts on this composition? 60-80% Icosapent Ethyl? How can this be considered a bio equivalent generic? (Twitter) - Nov 6, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Now published online in @CircAHA, print to follow! Reduction in Revascularization with Icosapent Ethyl: Insights from REDUCE-IT REVASC https://t.co/JbheaWAJD1 #cardiotwitter @benpeterson71 @gabrielsteg @CMichaelGibson @duanepinto @mmillermd1 @BudoffMd @CBallantyneMD @cpcannon (Twitter) - Nov 5, 2020
- ||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
Clinical: Compared with placebo, icosapent ethyl reduced first and total MACE in patients with prior PCI, according to results from REDUCE-IT PCI #TCTConnect #TCT2020 @TCTConference #cardiotwitter @dlbhattmd @BrighamWomens @agershlick https://t.co/wv2WVYNzyc (Twitter) - Nov 3, 2020
- |||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
Clinical: Icosapent ethyl reduces CV events in patients with prior PCI: REDUCE-IT PCI https://t.co/JSyCj0rWwa #cardiotwitter #cardiology @benpeterson71 (Twitter) - Nov 3, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
@DLBHATTMD Dear Dr Bhatt I was recently asked to give a presentation on Icosapent ethyl in Alexandria, I’d appreciate your suggestions on the list of trials (Twitter) - Nov 2, 2020
- | Vascepa (icosapent ethyl) / Amarin, HLS Therap
Journal: Federal judge invalidates icosapent ethyl patents - but on the basis of a common statistical mistake. (Pubmed Central) - Nov 1, 2020
In statin-treated patients with elevated triglycerides and a history of PCI, the addition of icosapent ethyl significantly reduced ischemic events, with relative and absolute risk reductions that were substantial. No abstract available
- ||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
What would it take for one of you 3 to get @DLBHATTMD on your show? With impending US disaster, there is probably a role for #Vascepa in mitigation. @drbeen_medical @YoDoctorYo #COVID19 #longhaulers @Amarincorp (Twitter) - Oct 31, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Vascepa and Covid? Canadá trial? (Twitter) - Oct 29, 2020
- | Vascepa (icosapent ethyl) / Amarin, HLS Therap
Vascepa. (Twitter) - Oct 27, 2020
- || Vascepa (icosapent ethyl) / Amarin, HLS Therap
Started on Vascepa 9 months ago and my triglycerides are down 50%! Working for me (Twitter) - Oct 26, 2020
- ||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
5/ #Triglycerides Vascepa Reduce-it trial. A tremendous success! https://t.co/EIOzo1mHYZ @DaveKeto @FatEmperor @Gearoidmuar @gerdosi @DrPaulMason @AZMD1 @ZKForTre (Twitter) - Oct 26, 2020
- |||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
Head-to-Head: 4/ #Triglcyerides #Vascepa I pay $30 for my fish oil for a 3 month supply I take 4 tabs a day @nationallipid @SethJBaumMD @mdavidsonmd I would like to see a head to head trial of Vasepa vs Lovaza. It will never happen. (Twitter) - Oct 26, 2020
- |||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
Clinical: Proud to be bringing Icosapent-Ethyl to prevent cardiovascular disease and age-related chronic inflammation in the UK population & globally by using computational modelling @EMJCardiology @DLBHATTMD @Drlipid @ExpertLipid @maciejbanach @escardio #REDUCEIT https://t.co/Cklu7dcRlD (Twitter) - Oct 26, 2020
- ||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk Reduction: https://t.co/3gjLRSzsLt #cardiotwitter #cardiology #prevention @wendywangmd @ArodaMd (Twitter) - Oct 24, 2020
- ||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
Clinical: Yah. Puzzling. Would like to see #STRENGTH report out EPA, EPA/AA ratio. I do have 3 pts on vascepa who have achieved 140+ mcg/mL. However, EPA/AA are all 0.4 and less 🧐. Nowhere near 0.75. (Twitter) - Oct 23, 2020
- ||| Vascepa (icosapent ethyl) / Amarin, HLS Therap, Epanova (eicosapentaenoic acid/docosahexaenoic acid) / AstraZeneca
Here’s the data. Epanova 4g/d blood EPA went from 25.7 to 170 ug/ml (+406%) and Vascepa 4g/d blood EPA went from 26.1 to 144 ug/ml (+394%) (Twitter) - Oct 23, 2020
- ||| Vascepa (icosapent ethyl) / Amarin, HLS Therap
4/ #Vascepa Compare Vascepa to Lovaza. https://t.co/0GaHX1N4jh I need someone to convince the larger fluffier LDLc is a problem. (Twitter) - Oct 23, 2020